Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Brain Res ; 1648(Pt B): 603-616, 2016 10 01.
Article in English | MEDLINE | ID: mdl-26923166

ABSTRACT

In neurological disorders, both acute and chronic neural stress can disrupt cellular proteostasis, resulting in the generation of pathological protein. However in most cases, neurons adapt to these proteostatic perturbations by activating a range of cellular protective and repair responses, thus maintaining cell function. These interconnected adaptive mechanisms comprise a 'proteostasis network' and include the unfolded protein response, the ubiquitin proteasome system and autophagy. Interestingly, several recent studies have shown that these adaptive responses can be stimulated by preconditioning treatments, which confer resistance to a subsequent toxic challenge - the phenomenon known as hormesis. In this review we discuss the impact of adaptive stress responses stimulated in diverse human neuropathologies including Parkinson׳s disease, Wolfram syndrome, brain ischemia, and brain cancer. Further, we examine how these responses and the molecular pathways they recruit might be exploited for therapeutic gain. This article is part of a Special Issue entitled SI:ER stress.


Subject(s)
Autophagy , Nervous System Diseases , Proteostasis Deficiencies/complications , Unfolded Protein Response/physiology , Animals , Endoplasmic Reticulum Stress/physiology , Humans , Nervous System Diseases/complications , Nervous System Diseases/metabolism , Nervous System Diseases/therapy , Proteasome Endopeptidase Complex/metabolism , Signal Transduction , Ubiquitin/metabolism
2.
Mol Neurobiol ; 53(3): 1540-1550, 2016 Apr.
Article in English | MEDLINE | ID: mdl-25663136

ABSTRACT

Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) has become a routine method in many laboratories. Normalization of data from experimental conditions is critical for data processing and is usually achieved by the use of a single reference gene. Nevertheless, as pointed by the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines, several reference genes should be used for reliable normalization. Ageing is a physiological process that results in a decline of many expressed genes. Reliable normalization of RT-qPCR data becomes crucial when studying ageing. Here, we propose a RT-qPCR study from four mouse brain regions (cortex, hippocampus, striatum and cerebellum) at different ages (from 8 weeks to 22 months) in which we studied the expression of nine commonly used reference genes. With the use of two different algorithms, we found that all brain structures need at least two genes for a good normalization step. We propose specific pairs of gene for efficient data normalization in the four brain regions studied. These results underline the importance of reliable reference genes for specific brain regions in ageing.


Subject(s)
Aging/genetics , Brain Chemistry/genetics , Gene Expression Profiling , Nerve Tissue Proteins/biosynthesis , Algorithms , Animals , Cerebellum/metabolism , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , Corpus Striatum/growth & development , Corpus Striatum/metabolism , Hippocampus/metabolism , Male , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction
3.
Rev Mal Respir ; 31(10): 992-1002, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25442121

ABSTRACT

Alpha-1 antitrypsin (α1-AT) is the most abundant circulating protease inhibitor. The common severe Z allele of α1-AT (Glu342Lys) causes the protein to form ordered polymers that are retained within the endoplasmic reticulum of hepatocytes. These polymers form the periodic acid-Schiff positive inclusions that are associated with cirrhosis. The lack of circulating α1-AT predisposes the Z α1-AT homozygote to early onset emphysema. We review here the molecular basis of α1-AT deficiency and show how understanding the liver disease provides new insights in the pathobiology of the associated emphysema. The mechanism of α1-AT deficiency provides a paradigm for a wider group of conditions that we have termed the serpinopathies. We also examine the strategies that are being pursued to develop novel therapies for α1-AT deficiency. This review considers our understanding of the pathobiology of α1-AT deficiency and then illustrate the therapeutic possibilities that can ensue once we understand basic mechanisms of disease.


Subject(s)
alpha 1-Antitrypsin Deficiency/genetics , Animals , Humans , Models, Molecular , Protein Structure, Tertiary , Pulmonary Disease, Chronic Obstructive/genetics , Pulmonary Disease, Chronic Obstructive/pathology , Pulmonary Disease, Chronic Obstructive/therapy , alpha 1-Antitrypsin/chemistry , alpha 1-Antitrypsin Deficiency/pathology , alpha 1-Antitrypsin Deficiency/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...